DRUG STRATEGIES
2101 L STREET 800, WASHINGTON, DC 20037 www.drugstrategies.com

Total Revenue
$192,630
Total Expenses
$312,252
Net Assets
$724,735

Organizations Filed Purposes: DRUG STRATEGIES PROMOTES MORE EFFECTIVE APPROACHES TO THE NATION'S DRUG PROBLEMS AND SUPPORTS PRIVATE AND PUBLIC EFFORTS TO REDUCE THE DEMAND FOR DRUGS THROUGH PREVENTION, EDUCATION, TREATMENT, LAW ENFORCEMENT AND COMMUNITY INITIATIVES.

DRUG STRATEGIES CONDUCTED A MAJOR STUDY OF STATE INITIATIVES TO REDUCE OVERDOSE DEATHS FROM FENTANYL, A SYNTHETIC OPIOID ONE HUNDRED TIMES MORE DEADLY THAN HEROIN. IN PREPARING THIS REPORT, DRUG STRATEGIES COLLABORATED WITH SHATTERPROOF, A NATIONWIDE PROGRAM TO INCREASE THE AVAILABILITY OF DRUG TREATMENT AND REDUCE THE ADVERSE CONSEQUENCES OF ADDICTION. TOGETHER, THE TWO ORGANIZATIONS BRIEFED GOVERNORS' KEY STAFF MEMBERS IN A DOZEN STATES ABOUT THE STEPS THEY CAN TAKE TO REDUCE OVERDOSE DEATHS. THE REPORT , "THE FENTANYL EPIDEMIC: STATE INITIATIVES TO REDUCE OVERDOSE DEATHS," IS WIDELY AVAILABLE ONLINE.

Executives Listed on Filing

Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing

NameTitleHours Per WeekTotal Salary
Mathea FalcoEXECUTIVE DIRECTOR/PRESIDENT40$42,000
Phillip B HeymannBOARD CHAIR1$0
Charles KirkwoodDIRECTOR1$0
Dr A Thomas MclellanDIRECTOR1$0
Hubert WilliamsDIRECTOR1$0
Marni VlietDIRECTOR1$0
Ambassador James R JonesDIRECTOR1$0
Michael KantorDIRECTOR1$0
Morris PannerDIRECTOR1$0
Louise BrysonDIRECTOR1$0
Marian Wright EdelmanDIRECTOR1$0
Dr David KesslerDIRECTOR1$0
Mark KleimanDIRECTOR1$0

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202012559349300306_public.xml

View Statistics by Area